The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Role of Pressure Wire in Coronary Artery Disease

관상동맥 질환에서 압력철선의 유용성

  • Nam, Chang-Wook (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center)
  • 남창욱 (계명대학교 동산의료원 심장내과)
  • Published : 2011.12.01
⟨ Previous Next ⟩

Abstract

To get the best clinical outcome after revascularization, understanding of patient and lesion should proceed. Although coronary angiography has been regarded as the gold standard for assessing coronary artery disease for several decades, it has several well-known limitations. Fractional flow reserve (FFR), measured with a coronary pressure wire, is an accurate and lesion-specific index for determining the functional significance (myocardial ischemia) of a particular stenosis. The selection of target vessels, the decision and method for revascularization, and the determination of prognosis in patients with CAD can be helped by FFR in daily practice. In this manuscript, we will review the role of pressure wire and discuss the limitation of it in evaluating CAD.

Keywords

References

  1. Meneses Hoyos J, Gomez Del Campo C. Angiography of the thoracic aorta and coronary vessels, with direct injection of an opaque solution into the aorta. Radiology 1948;50:211-213. https://doi.org/10.1148/50.2.211
  2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. https://doi.org/10.1056/NEJMoa035071
  3. Marcus ML, Skorton DJ, Johnson MR, Collins SM, Harrison DG, Kerber RE. Visual estimates of percent diameter coronary stenosis: "a battered gold standard". J Am Coll Cardiol 1988;11:882-885. https://doi.org/10.1016/0735-1097(88)90226-4
  4. Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the sirolimus-eluting balloon expandable stent in the treatment of patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004;110:508-514. https://doi.org/10.1161/01.CIR.0000136821.99814.43
  5. Yan BP, Gurvitch R, Ajani AE. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Cardiovasc Revasc Med 2006;7:155-158. https://doi.org/10.1016/j.carrev.2006.04.001
  6. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Catheter Cardiovasc Interv 2007;69:334-340. https://doi.org/10.1002/ccd.21124
  7. Virmani R, Liistro F, Stankovic G, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002;106:2649-2651. https://doi.org/10.1161/01.CIR.0000041632.02514.14
  8. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-1367. https://doi.org/10.1161/01.CIR.87.4.1354
  9. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-1708. https://doi.org/10.1056/NEJM199606273342604
  10. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995;92:39-46. https://doi.org/10.1161/01.CIR.92.1.39
  11. De Bruyne B, Pijls NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001;104:157-162. https://doi.org/10.1161/01.CIR.104.2.157
  12. Kern MJ, Lerman A, Bech JW, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 2006;114: 1321-1341. https://doi.org/10.1161/CIRCULATIONAHA.106.177276
  13. De Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 1996;94:1842-1849. https://doi.org/10.1161/01.CIR.94.8.1842
  14. Bech GJ, De Bruyne B, Pijls NH, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001;103: 2928-2934. https://doi.org/10.1161/01.CIR.103.24.2928
  15. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-2111. https://doi.org/10.1016/j.jacc.2007.01.087
  16. Koo BK, Yang HM, Doh JH, et al. Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations. JACC Cardiovasc Interv 2011;4:803-811. https://doi.org/10.1016/j.jcin.2011.03.013
  17. Kang SJ, Lee JY, Ahn JM, et al. Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity. Circ Cardiovasc Interv 2011;4:65-71. https://doi.org/10.1161/CIRCINTERVENTIONS.110.959148
  18. Nam CW, Yoon HJ, Cho YK, et al. Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasoundguided. JACC Cardiovasc Interv 2010;3:812-817. https://doi.org/10.1016/j.jcin.2010.04.016
  19. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224. https://doi.org/10.1056/NEJMoa0807611
  20. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study. J Am Coll Cardiol 2010;56:177-184. https://doi.org/10.1016/j.jacc.2010.04.012
  21. Fearon WF, Bornschein B, Tonino PA, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010;122:2545-2550. https://doi.org/10.1161/CIRCULATIONAHA.109.925396
  22. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME Study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-2821. https://doi.org/10.1016/j.jacc.2009.11.096
  23. Pijls NH. Optimum guidance of complex PCI by coronary pressure measurement. Heart 2004;90:1085-1093. https://doi.org/10.1136/hrt.2003.032151
  24. Pijls NH, De Bruyne B, Bech GJ, et al. Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery: validation in humans. Circulation 2000;102:2371-2377. https://doi.org/10.1161/01.CIR.102.19.2371
  25. Koo BK, De Bruyne B. FFR in bifurcation stenting: what have we learned? EuroIntervention 2010;6(Suppl J):J94-J98. https://doi.org/10.4244/EIJV6SUPJA15
  26. Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633-637. https://doi.org/10.1016/j.jacc.2005.04.054
  27. Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J 2008;29:726-732. https://doi.org/10.1093/eurheartj/ehn045
  28. Nam CW, Hur SH, Koo BK, et al. Fractional flow reserve versus angiography in left circumflex ostial intervention after left main crossover stenting. Korean Circ J 2011;41:304-307. https://doi.org/10.4070/kcj.2011.41.6.304
  29. Lopez-Palop R, Pinar E, Lozano I, Saura D, Pico F, Valdes M. Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J 2004; 25:2040-2047. https://doi.org/10.1016/j.ehj.2004.07.016
  30. Nam CW, Rha SW, Koo BK, et al. Usefulness of coronary pressure measurement for functional evaluation of drug-eluting stent restenosis. Am J Cardiol 2011;107:1783-1786. https://doi.org/10.1016/j.amjcard.2011.02.328
  31. Pijls NH, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 2002;105:2950-2954. https://doi.org/10.1161/01.CIR.0000020547.92091.76
  32. Nam CW, Hur SH, Cho YK, et al. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol 2011;107:1763-1767. https://doi.org/10.1016/j.amjcard.2011.02.329
  33. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax Study. EuroIntervention 2009;5:50-56. https://doi.org/10.4244/EIJV5I1A9
  34. Wykrzykowska JJ, Garg S, Girasis C, et al. Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter LEADERS (limus eluted from a durable versus erodable stent coating) trial. J Am Coll Cardiol 2010; 56:272-277. https://doi.org/10.1016/j.jacc.2010.03.044
  35. Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTEX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-1218. https://doi.org/10.1016/j.jacc.2011.06.020
  36. Ntalianis A, Sels JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv 2010;3:1274-1281. https://doi.org/10.1016/j.jcin.2010.08.025
  37. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107:3129-3132. https://doi.org/10.1161/01.CIR.0000080700.98607.D1
  38. Fearon WF, Shah M, Ng M, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008;51:560-565. https://doi.org/10.1016/j.jacc.2007.08.062
  39. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2009;120:2271-2306. https://doi.org/10.1161/CIRCULATIONAHA.109.192663
  40. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-2555. https://doi.org/10.1093/eurheartj/ehq277